Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-06

Clinical Trial Update: Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome. [Phase 2]

View source ↗

Summary

Pilot Phase 2 trial investigating Qing-Re-Liang-Xue Decoction as complementary medicine for psoriasis vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qing-Re-Liang-Xue Decoction

Snippet

Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University | Conditions: Psoriasis Vulgaris | Phase 2 | Status: UNKNOWN